Nexus Surgical and Medicare Inc Stock Price Today (NSE: NEXUSSURGL)
Fundamental Score
Nexus Surgical and Medicare Inc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nexus Surgical and Medicare Inc share price today is ₹18.12, down 4.63% on NSE/BSE as of 4 August 2026. Nexus Surgical and Medicare Inc (NEXUSSURGL) is a Small-cap company in the Other Financial Services sector with a market capitalisation of ₹9.75 (Cr). The 52-week high for NEXUSSURGL share price is ₹25.50 and the 52-week low is ₹13.26. At a P/E ratio of 13.18x, NEXUSSURGL is currently trading below its industry average P/E of 27.57x. The company has a Return on Equity (ROE) of 51.75% and a debt-to-equity ratio of 0.00.
Nexus Surgical and Medicare Inc Share Price Chart — NSE/BSE Historical Performance
Nexus Surgical and Medicare Inc share price chart: -7.65% return over the past month. 52-week high ₹25.50, 52-week low ₹13.26.
Nexus Surgical and Medicare Inc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹19.05 | ₹19.85 | ₹17.50 | ₹18.49 | 2.29K (Cr) | |
| ₹19.00 | ₹21.89 | ₹18.04 | ₹18.71 | 3.19K (Cr) | |
| ₹19.00 | ₹19.00 | ₹18.00 | ₹18.96 | 3.51K (Cr) | |
| ₹18.00 | ₹19.00 | ₹18.00 | ₹18.73 | 371.00 (Cr) | |
| ₹18.60 | ₹19.00 | ₹18.01 | ₹18.92 | 1.00K (Cr) | |
| ₹19.00 | ₹20.00 | ₹17.27 | ₹19.00 | 3.04K (Cr) | |
| ₹20.00 | ₹20.00 | ₹17.00 | ₹19.15 | 1.73K (Cr) | |
| ₹19.00 | ₹19.90 | ₹18.30 | ₹18.91 | 3.65K (Cr) | |
| ₹21.98 | ₹21.98 | ₹17.99 | ₹18.88 | 688.00 (Cr) | |
| ₹19.50 | ₹19.50 | ₹18.00 | ₹18.34 | 6.92K (Cr) |
Nexus Surgical and Medicare Inc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹19.05 | ₹19.85 | ₹17.50 | ₹18.49 | -2.94% | |
| ₹21.20 | ₹23.95 | ₹17.00 | ₹18.71 | -11.75% | |
| ₹19.90 | ₹22.40 | ₹18.51 | ₹21.00 | +5.53% | |
| ₹20.39 | ₹25.50 | ₹18.02 | ₹19.90 | -2.40% | |
| ₹17.05 | ₹21.46 | ₹17.01 | ₹20.40 | +19.65% | |
| ₹17.65 | ₹19.50 | ₹16.02 | ₹16.03 | -9.18% | |
| ₹17.01 | ₹19.99 | ₹16.01 | ₹18.62 | +9.47% | |
| ₹19.40 | ₹19.40 | ₹15.26 | ₹17.75 | -8.51% | |
| ₹16.02 | ₹17.50 | ₹13.26 | ₹17.50 | +9.24% | |
| ₹18.10 | ₹19.99 | ₹14.55 | ₹16.00 | -11.60% | |
| ₹17.01 | ₹19.95 | ₹14.02 | ₹18.12 | +6.53% | |
| ₹17.59 | ₹22.00 | ₹16.00 | ₹16.59 | -5.69% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Micro-cap syringe trader, momentum fading, avoid the hype.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Nexus Surgical and Medicare's stock is currently Recent news includes the company submitting its SEBI certificate for Q4 FY26 on April 8, 2026. Prior to that, Markets Mojo downgraded the stock to 'Sell' on April 2, 2026, citing mixed technicals and valuation concerns.
CORE STORY (THE REAL GAME)
Commodity syringe trading play, not a healthcare revolution. Nexus Surgical is riding the wave of basic medical supply demand in a growing Indian market.
- Recent downgrade to 'Sell'
- Weak price momentum
- Concerns over valuation
- Significant order wins
- Successful expansion into higher-margin products
- Positive change in market sentiment
- Micro-cap: Illiquidity risk
- Low promoter holding: 18.73%
- Negative YoY profit growth in latest quarter
No FII/DII activity. Promoter holding stagnant.
Financial services sector in India is estimated to grow 7.4% in FY26, but Nexus Surgical's direct benefit is questionable.
Profit converting to cash, Free Cash Flow 5Y: ₹0.31 Cr
3-6 month thesis: Expect further price correction if growth doesn't rebound. Limited upside potential due to micro-cap nature.
Primary Thesis Risk
Illiquidity and reliance on low-margin commodity trading.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nexus Surgical and Medicare Inc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nexus Surgical and Medicare Inc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEXUSSURGL across key market metrics for learning purposes.
Positive Indicators
10 factors identified
Strong Return on Equity (51.75%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (69.23%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 13.18 vs Industry: 27.57)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (166.67%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (38.51%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (16.04% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (37.60% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (37.60% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Low Promoter Commitment (18.73%)
Observation: Reduced promoter stake may indicate limited confidence.
Analysis: Low promoter holding may raise questions about management commitment.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nexus Surgical and Medicare Inc vs Other Financial Services Peers
Peer Comparison - Other Financial Services
Compare Nexus Surgical and Medicare Inc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Nexus Surgical and Medicare IncNexus Surgical ...Selected✓ NEXUSSURGL • 538874 | 63.8/100 | ₹18.12₹18 | ₹9.75₹9.75 | 13.18Average 13.2 Average | 51.75%Excellent 51.75% Excellent | 69.23%Excellent 69.23% Excellent | 0.00Excellent 0.0 Excellent | 37.60%Excellent 37.60% Excellent | 16.04%Excellent 16.04% Excellent | 0.00% |
Crisil LtdCrisil Ltd... CRISIL • 500092 | 66.4/100 | ₹4359.80₹4360 | ₹30810.19₹30810.19 | 36.70Average 36.7 Average | 24.46%Excellent 24.46% Excellent | 32.55%Excellent 32.55% Excellent | 0.10Excellent 0.1 Excellent | 14.40%Good 14.40% Good | 12.99%Good 12.99% Good | 0.59% |
RRPSemiconductorRRPSemiconducto... RRPS • 504346 | 8/100 | ₹8894.60₹8895 | ₹12118.00₹12118.00 | — — | -61.01%Poor -61.01% Poor | -32.66%Poor -32.66% Poor | 0.65Good 0.7 Good | — — | — — | 0.00% |
Dhani Services LtdDhani Services ... DHANI • 532960 | 20.9/100 | ₹51.06₹51 | ₹3896.81₹3896.81 | 114.92Average 114.9 Average | -1.81%Poor -1.81% Poor | 1.39%Poor 1.39% Poor | 0.18Excellent 0.2 Excellent | — — | -32.89%Poor -32.89% Poor | 0.00% |
COLAB PLATFORMS LIMITEDCOLAB PLATFORMS... COLAB • 542866 | 45/100 | ₹140.50₹141 | ₹2923.32₹2923.32 | 619.35Average 619.4 Average | 17.53%Good 17.53% Good | 24.27%Excellent 24.27% Excellent | 0.00Excellent 0.0 Excellent | 198.76%Excellent 198.76% Excellent | 356.32%Excellent 356.32% Excellent | 0.01% |
ALGOQUANTALGOQUANT... ALGOQUANT • 505725 | 57.7/100 | ₹68.24₹68 | ₹1706.53₹1706.53 | 52.12Average 52.1 Average | 27.69%Excellent 27.69% Excellent | 31.43%Excellent 31.43% Excellent | 0.25Excellent 0.3 Excellent | 67.14%Excellent 67.14% Excellent | 111.83%Excellent 111.83% Excellent | 0.00% |
LKP Finance LtdLKP Finance Ltd... LKPFIN • 507912 | 53.9/100 | ₹189.35₹189 | ₹1251.64₹1251.64 | 57.39Average 57.4 Average | 5.24%Poor 5.24% Poor | 6.77%Poor 6.77% Poor | 0.00Excellent 0.0 Excellent | -18.20%Poor -18.20% Poor | 31.70%Excellent 31.70% Excellent | 0.00% |
Centrum Capital LtdCentrum Capital... CENTRUM • 501150 | 0/100 | ₹23.73₹24 | ₹1165.87₹1165.87 | — — | -75.34%Poor -75.34% Poor | 7.45%Poor 7.45% Poor | 51.52Poor 51.5 Poor | — — | 49.24%Excellent 49.24% Excellent | 0.00% |
85/100 | ₹959.05₹959 | ₹1037.75₹1037.75 | 26.84Average 26.8 Average | 27.71%Excellent 27.71% Excellent | 34.63%Excellent 34.63% Excellent | 0.00Excellent 0.0 Excellent | 24.61%Excellent 24.61% Excellent | 22.75%Excellent 22.75% Excellent | 2.10% | |
Prime Securities LtdPrime Securitie... PRIMESECU • 500337 | 35.4/100 | ₹276.90₹277 | ₹936.59₹936.59 | 98.90Average 98.9 Average | 4.09%Poor 4.09% Poor | 8.25%Poor 8.25% Poor | 0.01Excellent 0.0 Excellent | 2.90%Average 2.90% Average | 25.66%Excellent 25.66% Excellent | 0.54% |
63.7/100 | ₹281.55₹282 | ₹614.86₹614.86 | 21.22Average 21.2 Average | 20.57%Excellent 20.57% Excellent | 27.26%Excellent 27.26% Excellent | 0.17Excellent 0.2 Excellent | 31.11%Excellent 31.11% Excellent | 48.53%Excellent 48.53% Excellent | 0.00% | |
Top Other Financial Services Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Crisil Ltd share price30810.19 Cr
- RRPSemiconductor share price12118.00 Cr
- Dhani Services Ltd share price3896.81 Cr
- COLAB PLATFORMS LIMITED share price2923.32 Cr
- ALGOQUANT share price1706.53 Cr
Nexus Surgical and Medicare Inc PE Ratio History
Historical price-to-earnings ratio for NEXUSSURGL — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.39 | ₹27.68 | 71x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nexus Surgical and Medicare Inc Quarterly Performance
Latest quarterly metrics for NEXUSSURGL — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
38.51%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
166.67%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
16.04%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
37.60%
Compounded annual net profit growth over 5 years
Nexus Surgical and Medicare Inc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NEXUSSURGL — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nexus Surgical and Medicare Inc Financial Statements
Annual income statement, balance sheet and cash flow for Nexus Surgical and Medicare Inc (NEXUSSURGL) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Nexus Surgical and Medicare Inc
About NEXUSSURGL (Nexus Surgical and Medicare Inc)
Nexus Surgical and Medicare Inc. (NEXUSSURGL) is a multifaceted entity operating within the financial services sector, strategically positioned to bridge the gap between healthcare... and capital markets. NEXUSSURGL specializes in facilitating financial solutions that empower healthcare providers and institutions. The company employs innovative financial instruments and strategic partnerships to optimize resource allocation, enabling advancements in patient care and medical technology adoption. By understanding the intricate financial needs of the healthcare landscape, NEXUSSURGL provides tailored services designed to foster stability and growth within the medical community. NEXUSSURGL focuses on creating financial ecosystems that support the healthcare industry's long-term viability. This involves connecting investors with promising ventures, streamlining financial processes for medical facilities, and promoting responsible financial practices within the sector. The company’s commitment to ethical and transparent operations ensures that financial decisions are aligned with the best interests of both investors and healthcare providers. By fostering collaboration and offering specialized financial expertise, NEXUSSURGL aims to drive innovation and improve access to quality healthcare. NEXUSSURGL distinguishes itself through its holistic approach, integrating financial acumen with a deep understanding of the healthcare industry's unique challenges and opportunities. The company provides a range of services, from financial consulting and investment management to strategic planning and capital acquisition. NEXUSSURGL's team of experienced professionals combines financial expertise with medical knowledge to offer comprehensive solutions that address the diverse financial needs of healthcare organizations. Through its commitment to excellence and a customer-centric approach, NEXUSSURGL seeks to be a trusted partner in driving the financial health and sustainable growth of the healthcare sector.
Company Details
Key Leadership
NEXUSSURGL Share Price: Frequently Asked Questions
What is the current share price of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc (NEXUSSURGL) trades at ₹18.12 on NSE and BSE. Market cap ₹9.75 (Cr). Educational data only.
What is the P/E ratio of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has a P/E of 13.18x vs industry average 27.57x.
What is the Bull Run score for Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has a Bull Run score of 63.8/100 based on 25+ financial parameters.
Does Nexus Surgical and Medicare Inc pay dividends?
Nexus Surgical and Medicare Inc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has ROE of 51.75%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nexus Surgical and Medicare Inc?
Nexus Surgical and Medicare Inc has debt-to-equity of 0.00.
Is Nexus Surgical and Medicare Inc a good investment?
Bull Run gives Nexus Surgical and Medicare Inc a score of 63.8/100. This is not investment advice — consult a SEBI-registered advisor.